TITLE

Ischemic Colitis Associated With Use of a Bitter Orange-Containing Dietary Weight-Loss Supplement

AUTHOR(S)
Sultan, Shahnaz; Spector, Jeremy; Mitchell, Robert M.
PUB. DATE
December 2006
SOURCE
Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1630
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Since the US Food and Drug Administration banned the use of dietary supplements containing ephedra in February 2004, numerous "ephedra-free" weight-loss products have appeared on the market. Many of these supplements contain compounds such as bitter orange that are similar in structure and action to ephedra. We describe a patient in whom ischemic colitis developed 1 week after initiation of a bitter orange-containing weight-loss supplement. The patient had no other predisposing factors, and discontinuation of the supplement led to immediate improvement and ultimate resolution of her symptoms. Both consumers and health care professionals should be aware of the potential harm that bitter orange-containing dietary supplements can cause and report such adverse events to the US Food and Drug Administration.
ACCESSION #
24100740

 

Related Articles

  • Herb curbed. Fields, Helen // U.S. News & World Report;1/12/2004, Vol. 136 Issue 1, p53 

    Reports on the Food & Drug Administration ban on ephedra which is also known as Ma-Huang. Linking of the herbal supplement to heart attacks, strokes and death; Duty of the FDA to prove the supplement unsafe as supplement makers do not have to prove their products are safe or effective;...

  • FDA Issues Regulation Prohibiting Sale of Dietary Supplements Containing Ephedra. Ressel, Genevieve // American Family Physician;3/15/2004, Vol. 69 Issue 6, p1343 

    Reports that the U.S. Food and Drug Administration has issued a final rule that prohibited the sale of dietary supplements containing ephedra. Side effects of ephedra.

  • STEMI in a 24-Year-Old Man after Use of a Synephrine-Containing Dietary Supplement. Thomas, John E.; Munir, Jamalah A.; McIntyre, Peter Z.; Ferguson, Michael A. // Texas Heart Institute Journal;2009, Vol. 36 Issue 6, p586 

    Billions of dollars are spent annually in the United States in the largely unregulated market of dietary supplements. Many of these supplements are marketed as weight-loss and athletic-performance-enhancement products. The association of various ephedra-containing products with adverse...

  • Death by Dietary Supplement? Miller, Henry I.; Longtin, David // Nutrition Health Review: The Consumer's Medical Journal;2000, Issue 80, p4 

    Discusses potential problems associated with dietary supplements in the United States. Questions on the safety of the products; Implementation of regulations by the US Food and Drug Administration; Adverse reactions and fatalities associated with the products.

  • POISON-PILL WATCH. Stein, Lisa // U.S. News & World Report;4/12/2004, Vol. 136 Issue 12, p12 

    Reports that the U.S. FDA is starting to crack down on makers of previously unregulated dietary supplements. Details of the FDA's ban on diet aid ephedra; Details of new safety guidelines on vitamins and herbal remedies issued by the Institute of Medicine; Report that among the dietary...

  • Making cosmetic dermatology safer. Schlessinger, Joel // Dermatology Times;Feb2008, Vol. 29 Issue 2, p3 

    The author reflects on the spread of the forms of phosphatidylcholine and deoxycholate (PC/DC) in the U.S. market. PC/DC, which has no drug approval from the Food and Drug Administration (FDA), are injected into the bodies of patients seeking for a fast weight loss. He cites that there are many...

  • Losing a Lot More Than Weight. Davies, Carol // Brandweek;8/6/2007, Vol. 48 Issue 29, p35 

    The article discusses how drug maker GlaxoSmithKline is planning to launch a new drug called Alli, which is the first ever over-the-counter diet pill that is approved by the U.S. Food and Drug Administration. The article explains that Alli works by blocking absorption of about 25% of ingested...

  • Herbal phen/fen.  // Healthy Weight Journal;Sep/Oct97, Vol. 11 Issue 5, p86 

    Reports that the US Food and Drug Administration has received complaints regarding ephedrine, which is an ingredient in the Herbal Phen/Fen weight loss food supplement marketed by Nutri/System. Chinese medicinal herb used to treat asthma and Saint Johnswort.

  • GlaxoSmithKline Petitions FDA to Disallow Weight Loss Claims for Dietary Supplements. Saxton, Kelly E. // HerbalGram;Aug-Oct2008, Issue 79, p66 

    The article reports that on April 17, 2008, GlaxoSmithKline (GSK), has filed a citizen petition to the Food and Drug Administration (FDA) to classify weight loss claims as disease claims. This would require all weight loss claims for dietary supplements to be pre-approved by the U.S. Food and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics